Synthesis, evaluation, and molecular docking studies of aryl urea-triazole-based derivatives as anti-urease agents

© 2018 Deutsche Pharmazeutische Gesellschaft..

Considering the importance of urease inhibitors in the treatment of ureolytic bacterial infections, in this work, the synthesis of novel, aryl urea-triazole-based derivatives as effective urease inhibitors is described. Dichloro-substituted derivative 4o, with IC50  = 22.81 ± 0.05 μM, is found to be the most potent urease inhibitor, determined by Berthelot colorimetric assay. Docking studies were also carried out for compound 4o to confirm the effective interactions with the urease active site.

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:351

Enthalten in:

Archiv der Pharmazie - 351(2018), 7 vom: 24. Juli, Seite e1800005

Sprache:

Englisch

Beteiligte Personen:

Moghimi, Setareh [VerfasserIn]
Goli-Garmroodi, Fereshteh [VerfasserIn]
Allahyari-Devin, Maryam [VerfasserIn]
Pilali, Hedieh [VerfasserIn]
Hassanzadeh, Malihe [VerfasserIn]
Mahernia, Shabnam [VerfasserIn]
Mahdavi, Mohammad [VerfasserIn]
Firoozpour, Loghman [VerfasserIn]
Amanlou, Massoud [VerfasserIn]
Foroumadi, Alireza [VerfasserIn]

Links:

Volltext

Themen:

8W8T17847W
Click reaction
Docking study
EC 3.5.1.5
Enzyme Inhibitors
Journal Article
Triazole
Triazoles
Urea
Urease

Anmerkungen:

Date Completed 19.10.2018

Date Revised 19.10.2018

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/ardp.201800005

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM284432288